Novel LRRK2 mutation in the Roc domain in an Western Australian family with autosomal dominant late-onset Parkinson's disease (LOPD)

被引：0
|
作者：
Mastaglia, F. L.
Huang, Y.
Halliday, G. M.
Rowe, D. B.
Sue, C. M.
机构：
来源：
MOVEMENT DISORDERS | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
729
引用
收藏
页码：S224 / S224
页数：1
相关论文
共 50 条
  • [31] LRRK2 mRNA and protein expression in Parkinson's disease cases with LRRK2 G2019S mutation
    Sharma, S.
    Bandopadhyay, R.
    Kingsbury, A. E.
    Lashley, T. C.
    Lees, A. J.
    Revesz, T.
    Wood, N. W.
    Holton, J. L.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 27 - 28
  • [32] LRRK2 R1441C mutation causing Parkinson's Disease in an Egyptian family
    Ali, Shan
    Wszolek, Zbigniew K.
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2022, 56 (02) : 191 - 192
  • [33] Novel SNCA mutation causes autosomal dominant Parkinson's disease
    Martikainen, M. H.
    Paivarinta, M.
    Hietala, M.
    Kaasinen, V.
    MOVEMENT DISORDERS, 2014, 29 : S56 - S56
  • [34] Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease
    Waro, Bjorg Johanne
    Aasly, Jan O.
    BRAIN AND BEHAVIOR, 2018, 8 (01):
  • [35] Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
    Paula Ramos-Gonzalez
    Susana Mato
    Juan Carlos Chara
    Alexei Verkhratsky
    Carlos Matute
    Fabio Cavaliere
    npj Parkinson's Disease, 7
  • [36] Screening for LRRK2 mutations in patients with Parkinson's disease in Russia:: identification of a novel LRRK2 variant
    Pchelina, S. N.
    Yakimovskii, A. F.
    Emelyanov, A. K.
    Ivanova, O. N.
    Schwarzman, A. L.
    Singleton, A. B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (07) : 692 - 696
  • [37] A novel PSEN1 mutation in a family with late-onset Alzheimer's disease
    Ricca, I.
    Valente, M.
    Grieco, G. S.
    Bini, P.
    Vitali, P.
    Cereda, C.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 : S29 - S29
  • [38] The LRRK2 R1441H mutation and Parkinson's disease
    Guedes, L. Correia
    Quadri, M.
    Bonifati, V.
    Ferreira, J. J.
    MOVEMENT DISORDERS, 2013, 28 : S408 - S409
  • [39] Novel Macrocyclic LRRK2 Inhibitors for Treating Parkinson's Disease
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022,
  • [40] Astrocytic atrophy as a pathological feature of Parkinson's disease with LRRK2 mutation
    Ramos-Gonzalez, Paula
    Mato, Susana
    Chara, Juan Carlos
    Verkhratsky, Alexei
    Matute, Carlos
    Cavaliere, Fabio
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
12345